Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP)-5b in pre-dialysis CKD patients

Japanese Journal of Nephrology

Volumn 52, Issue 8, 2010, Pages 1022-1028

  Shiota, Jun ^a   Izumi, Naoki ^a   Kasahara, Hitoshi ^a   Tagawa, Hitoshi ^a   Chiba, Tetsuo ^b   Nihei, Hiroshi ^b  

^a Kichijoji Asahi Hospital   (Japan)

^b Yokohama Daiichi Hospital   (Japan)

Author keywords

CKD; OPG; RANKL; TRACP 5b; Vascular calcification

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALBUMIN; ALKALINE PHOSPHATASE BONE ISOENZYME; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ABDOMINAL AORTIC CALCIFICATION SCORE; ALBUMIN BLOOD LEVEL; ARTERY CALCIFICATION; ARTERY CALCIFICATION SCORE; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; SCORING SYSTEM;

ACID PHOSPHATASE; AORTA, ABDOMINAL; AORTIC DISEASES; BIOLOGICAL MARKERS; CALCINOSIS; CORONARY DISEASE; CORONARY VESSELS; DIALYSIS; FEMALE; HUMANS; ISOENZYMES; LOGISTIC MODELS; MALE; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND;

EID: 79551575253     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bunnett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. Osteoprotegerin : a novel secreted protein involved in the regulation of bone density. Cell 1997 ; 89 : 309-319.
2. D'Amelio P, Isaia G, Isaia GC. The osteoprotegerin/RANK/RANKL system : A bone key to vascular disease. J Endocrinol Invest 2009 ; 32 : 6-9.
3. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcification, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertens 2001 ; 38 : 938-942.
4. Russo D, Palmiero G, DeBlasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 2004 ; 44 : 1024-1030.
5. Mikami S, Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Matsuhisa M, Ito T, Imai E, Hori M. Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. Hypertens Res 2008 ; 31 : 1163-1170.
6. Morena M, Dupuy AM, Jaussent I, Vernhet H, Gahide G, Klouche K, Bargnoux AS, Delcourt C, Canaud B, Cristol JP. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Nephrol Dial Transplant 2009 ; 24 : 3389-3397.
7. Mesquita M, Demulder A, Damry N, Melot C, Wittersheim E, Willems D, Dratwa M, Bergmann P. Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Clin Chem Lab Med 2009 ; 47 : 339-346.
8. Massy ZA, Mentaverri R, Mozar A, Brazier M, Kamel S. The pathophysiology of vascular calcification : are osteoclast-like cells the missing link? Diabetes Metab 2008 ; 34 : S16-S20.
9. Doherty TM, Uzui H, Fitzpatrick LA, Tripathi PV, Dunstan CR, Asotra K, Rajavashisth TB. Rationale for the role of osteoclast-like cells in arterial calcification. FASEB J 2002 ; 16 : 577-582.
10. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998 ; 12 : 1260-1268.
11. Orita Y, Yamamoto H, Kohno N, Sugihara M, Honda H, Kawamata S, Mito S, Soe N, Yoshizumi M. Role of osteoprotegerin in arterial calcification. Development of new animal model. Arterioscler Thromb Vasc Biol 2007 ; 27 : 2058-2064.
12. Min H, Morony S, Sarosi I, Dunstan CR, Capparelli C, Scully S, Van G, Kaufman S, Kostenuik PJ, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 2000 ; 192 : 463-474.
13. Olensen P, Ledet T, Rasmussen LM. Arterial osteoprotegerin : increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha. Diabetologia 2005 ; 48 : 561-568
14. Circulation J 2009 ; 73 (Suppl III) : 1091-1114.
15. Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease : independence from renal dysfunction. Clin Endocrinol 2008 ; 69 : 189-196.
16. Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, Shimizu M, Miki T, Kim M, Nishizawa Y. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am J Kidney Dis 2002 ; 40 : 802-809.
17. Rumberger JA, Brundage BH, Rader DJ, Kodos G. Electron beam computed tomographic coronary calcium scanning : A review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999 ; 74 : 243-252.
18. Barreto DV, Barreto FC, Carvalho AB, Cuppari L, Cendoroglo M, Draibe SA, Moyses RMA, Neves KR, Jorgetti V, Blair A, Guiberteau R, Canziani MEF. Coronary calcification in hemodialysis patients : The contribution of traditional and uremia-related risk factors. Kidney Int 2005 ; 67 : 1576-1582.
19. Nitta K, Akiba T, Uchida K, Otsubo S, Takei T, Yumura W, Kabaya T, Nihei H. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. Nephrol Dial Tranplant 2004 ; 19 : 1886-1889.
20. Tomiyama C, Carvalho AB, Higa A, Jorgetti V, Draibe SA, Canziani MEF. Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment. J Bone Miner Res 2010 ; 25 : 499-504.
21. Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Tourna T, Takishita S. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004 ; 8 : 54-58.
22. Watanabe R, Lemos MM, Manfredi SR, Draibe SA, Canziani MEF. Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up. Clin J Am Soc Nephrol 2010 ; 5 : 189-194.
23. Schoppet M, Schaefer JR, Hofbauer LC. Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men. Circulation 2003 ; 107 : e76.
24. Jakob C, Goerke A, Terpos E, Sterz J, Heith M, von Metzler I, Muller C, Sezer O. Serum levels of total-RANKL in multiple myeloma. Clin Lymphoma Myeloma 2009 ; 9 : 430-435.